How Can Information Disparities on Emerging Therapies Be Addressed?
https://vimeo.com/926992036 How can gaps in information about emerging myeloma therapies be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses some demographic characteristics of information disparities and advice for myeloma experts and…
How Can Equitable CAR T-Cell Therapy Access Be Increased?
https://vimeo.com/926992122 How can CAR T-cell therapy access issues be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic explains some common access issues that can arise for patient CAR T care and some…
How Are Cultural and Language Barriers to CAR T Therapy Being Addressed?
https://vimeo.com/926992189 How are CAR T therapy barriers of cultural and language nature being addressed? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses research study results on access barriers and ways to create…
Roadblocks for Black and Latinx Patients From CAR T Trial Access
https://vimeo.com/926992230 What are CAR T-cell therapy roadblocks for Black and Latinx trial access? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses barriers that have been documented in clinical research and solutions and…
Reducing CAR T-Cell Therapy Barriers for Relapsed/Refractory Myeloma
https://vimeo.com/926992265 How can CAR T-cell therapy barriers for relapsed/refractory myeloma be reduced? Expert Dr. Sikander Ailawadhi from Mayo Clinic shares his perspective about barriers to CAR T and advice for patients to…
How Can CAR T-Cell Therapy Be Explained to Patients and Families?
https://vimeo.com/926992331 How can patients and families be educated about CAR T-cell therapy? Expert Dr. Sikander Ailawadhi from Mayo Clinic discusses the approach he takes to explaining the treatment to those new to…
Myeloma Patient Expert Q&A: Dr. Ola Landgren Resource Guide
Download Resource Guide Download Resource Guide See More from START HERE Myeloma
Evolving Myeloma Treatment Options: How You Can Access Cutting-Edge Care Resource Guide
Download Resource Guide Download Resource Guide See More from EVOLVE Multiple Myeloma
CAR T-Cell Therapy | Care and Monitoring Post-Treatment
https://vimeo.com/925006628 How are myeloma patients monitored after CAR T-cell therapy? Myeloma expert and researcher Dr. Beth Faiman explains the testing that takes place following CAR T-cell therapy, how long monitoring…
CAR T-Cell Therapy for Myeloma | What Are the Advantages?
https://vimeo.com/925006501 How has CAR T-cell therapy transformed care for myeloma patients? Myeloma expert and researcher Dr. Beth Faiman shares results from the KarMMa study that compared CAR T-cell therapy versus…
Recovering From CAR T-Cell Therapy | What Can Myeloma Patients Expect?
https://vimeo.com/925006363 What can myeloma patients expect after undergoing CAR T-cell therapy? Myeloma expert and researcher Dr. Beth Faiman discusses returning to life after the CAR T process, advice for physical…
CAR T-Cell Therapy | Key Considerations for Myeloma Patients
https://vimeo.com/925005821 Myeloma expert and researcher Dr. Beth Faiman shares key considerations when planning for CAR T-cell therapy. Dr. Faiman reviews which patients qualify for CAR T-cell therapy, key aspects for…